drug

ibalizumab

Marketedupdated 2mo ago

by Theratechnologies Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ibalizumab

—A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumabactive not recruitingn=168
phase3Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injectioncompletedn=43
—External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERAcompletedn=141

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 26m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

ibalizumab

Marketedupdated 2mo ago

by Theratechnologies Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ibalizumab

—A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumabactive not recruitingn=168
phase3Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injectioncompletedn=43
—External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERAcompletedn=141

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 26m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

ibalizumab

all catalysts(0)

Trials studying ibalizumab

News(0)

Report a data issue

comments(0)

ibalizumab

all catalysts(0)

Trials studying ibalizumab

News(0)

Report a data issue

comments(0)